Floatz logo

ALECTINIB

Drug Monitoring

University Medical Center GroningenSmall moleculePhase 4 / ApprovedActive
BB
65/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
50/ 100
Competitive Position
95/ 100

Competitive context

0 Active assets in the Drug Monitoring cohort.

Asset / SponsorPhaseRating

Same molecule, other indications

ALECTINIB is also rated in:

non-small cell lung carcinomaDormant
BB
Indicative ·
66 / 100
View asset →
Anaplastic Lymphoma Kinase Gene MutationDormant
BB
Indicative ·
65 / 100
View asset →
Anaplastic Lymphoma Kinase Gene TranslocationDormant
BB
Indicative ·
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →